Lorem ipsum dolor sit amet, consectetur adipiscing elit lobortis arcu enim urna adipiscing praesent velit viverra sit semper lorem eu cursus vel hendrerit elementum morbi curabitur etiam nibh justo, lorem aliquet donec sed sit mi at ante massa mattis.
Lorem ipsum dolor sit amet, consectetur adipiscing elit ut aliquam, purus sit amet luctus venenatis, lectus magna fringilla urna, porttitor rhoncus dolor purus non enim praesent elementum facilisis leo, vel fringilla est ullamcorper eget nulla facilisi etiam dignissim diam quis enim lobortis scelerisque fermentum dui faucibus in ornare quam viverra orci sagittis eu volutpat odio facilisis mauris sit amet massa vitae tortor condimentum lacinia quis vel eros donec ac odio tempor orci dapibus ultrices in iaculis nunc sed augue lacus
At risus viverra adipiscing at in tellus integer feugiat nisl pretium fusce id velit ut tortor sagittis orci a scelerisque purus semper eget at lectus urna duis convallis. porta nibh venenatis cras sed felis eget neque laoreet libero id faucibus nisl donec pretium vulputate sapien nec sagittis aliquam nunc lobortis mattis aliquam faucibus purus in.
Nisi quis eleifend quam adipiscing vitae aliquet bibendum enim facilisis gravida neque. Velit euismod in pellentesque massa placerat volutpat lacus laoreet non curabitur gravida odio aenean sed adipiscing diam donec adipiscing tristique risus. amet est placerat in egestas erat imperdiet sed euismod nisi.
“Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum”
Eget lorem dolor sed viverra ipsum nunc aliquet bibendum felis donec et odio pellentesque diam volutpat commodo sed egestas aliquam sem fringilla ut morbi tincidunt augue interdum velit euismod eu tincidunt tortor aliquam nulla facilisi aenean sed adipiscing diam donec adipiscing ut lectus arcu bibendum at varius vel pharetra nibh venenatis cras sed felis eget dolor cosnectur drolo.
MED1stMR plans to create an enhanced virtual environment and a training solution that combines virtual reality (VR) with haptic objects such as simulation mannequins and the measurement of stress data of first responders to implement artificial intelligence-based scenario control into a mixed reality (MR) solution to ultimately improve the performance of medical first responders while maintaining their resilience.
At the second consortium meeting of MED1stMR, representatives from all partner organisations got together online and on-site due to the hybrid nature of the meeting. The aim of the first day was to give an overview of the current status of the work packages (WPs) that have already started. The project is currently in the phase of intensive requirements analysis with the end users and the interim status from the observations, interviews and co-creation workshops was presented and discussed together. Furthermore the planning and outlook of the work packages with the technological developments for the biosensors, the manikin and the mixed reality (MR) system which will start soon was made. Also, the high-fidelity manikin and its functions were demonstrated by the partner D2D. Afterwards, we had a common dinner respecting the COVID rules at the meeting venue that was accompanied by networking and knowledge exchange in an informal setting. The project partners discussed all ideas and plans that were created throughout the day.
The second day started at the Fusion Arena Virtual Reality Center organised by our technology partner Refense. The goal of the day was to allow all partners to try the VR system and get an impression of its current capabilities and limitations. In a parallel session, AIT demonstrated their recently developed VR Co-creation tool that is used for the end user requirement workshops in WP2. Biological sensors of our partner PLUX were presented in a short demo by the AIT team. The day ended with a fruitful discussion and feedback session on the meeting experience – all partners were looking forward to a good collaboration in the next 2 ½ years of MED1stMR.
